‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
  • Consumer productsConsumer products
    • Home
    • Support
    • Product registration
    • My Philips
  • Healthcare professionalsHealthcare professionals
    • Home
    • Products
    • Services
    • Specialties
    • Solutions
  • Other business solutionsOther business solutions
    • Lighting
    • Automotive
    • Hearing solutions
    • More
    • Display solutions
    • Dictation Solutions
  • About usAbout us
    • Home
    • News
    • Investor Relations
    • Careers
    • More
    • Environmental, Social and Governance
    • Innovation
  • Contact and supportContact and support
    • Customer support
    • Professional healthcare support
    • Company contacts
  • Stay up-to-dateStay up-to-date
  • Select your country / languageGlobal / English
  • Privacy Notice
  • Terms of use
  • Cookie notice
  • Legal compliance
© Koninklijke Philips N.V., 2004 - 2025. All rights reserved.
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Philips VeriSight Pro 3D ICE Catheter

Philips VeriSight Pro 3D ICE Catheter

Streamline LAAO procedures

Take control of your LAAO program

Create a moderate sedation program that streamlines left atrial appendage occlusion (LAAO) procedures, while reducing costs and improving the patient experience. [1-3] With our economic framework and assessment, we can help individual institutions evaluate the overall financial impact of 3D ICE. Discover how Philips VeriSight Pro 3D ICE can transform your practice and contact your local VeriSight Pro representative today.

More confidence

Achieve the confidence of TEE imaging guidance with the benefits of intracardiac echo [4-6]

Increase efficiencies

Reduce procedure time and costs by removing general anesthesia for more efficient operations [1,2]

Improve satisfaction

Improve patient satisfaction with same-day discharges, shorter waiting times and reduced anxiety around general anesthesia [3]

Clear guidance

Navigate complex anatomy and tailor views with real-time, 360° visualization and digital steering to obtain all views from one catheter position.

VeriSight ICE in EP Lab Experience LAAO

Hear how the use of Philips VeriSight Pro 3D ICE Catheter has impacted one lab’s efficiency during LAAO procedures

  1. 28

    minutes average room time saved [1]

    28

    minutes average room time saved [1]

    LAAO procedures guided by VeriSight Pro can save significant lab time. General anesthesia is not required, allowing faster room turnover and reallocation of staff to other procedures to maximize your facility's productivity.

  2. 30%

    less costs than procedures with general anesthesia [2]

    30%

    less costs than procedures with general anesthesia [2]

    By eliminating general anesthesia and associated PACU care, reducing lab time and increasing same-day-discharge, labs can reduce overall hospital expenses and associated costs.

  3. 0.97 vs 1.35 days

    difference between ICE and TEE hospital stays [7]

    0.97 vs 1.35 days

    difference between ICE and TEE hospital stays [7]

    A retrospective, single-center study found Philips VeriSight Pro ICE resulted in shorter hospital stays compared to TEE during LAAO procedures. VeriSight Pro helps reduced readmissions and length of stay, providing a cost-efficient solution for LAAO procedures.

  4. 1.3% vs 95.6%

    difference between ICE and TEE PACU utilization [7]

    1.3% vs 95.6%

    difference between ICE and TEE PACU utilization [7]

    VeriSight Pro ICE had a dramatic reduction in PACU utilization compared to TEE in a recent study. ICE-guided procedures support same-day discharge and avoid anesthesia bottlenecks for enhanced workflows.

Exceptional insight, now in sight.

VeriSight Pro 3D ICE provides direct visualization, near-field imaging and real-time guidance inside the heart chambers, reducing the need for general anesthesia and minimizing catheter manipulation with its unique digital steering. [8]
Philips 3D ICE VeriSight Pro Catheter for LAA Closure: Step-by-step
Expert standardized imaging
Electrophysiology and interventional cardiology experts have collaborated to build step-by-step 3D ICE-guided LAAO protocols with VeriSight Pro to ensure all criteria for device placement and deployment imaging are confidently achieved.
Safe and efficient alternative to TEE [4-6]
A retrospective, single-center study found VeriSight Pro as a safe and efficient alternative to TEE, that can enhance procedural workflows, reduce GA, and lower overall care costs. [7] Furthermore, SCAI and HRS released a uniform recommendation that TEE or ICE can be used to guide LAAO procedures.
 VeriSight Pro 3D ICE on EPIQ Ultrasound System in Cath Lab during LAAO procedure
Simplify concomitant LAAO/ablation procedures
VeriSight Pro 3D ICE Catheter offers a single imaging solution to complete both the Afib ablation and LAAO procedures. Experience more efficient and effective interventions while also reducing imaging modalities and patient discomfort. [1,9-12] Watch a live case and expert discussion.
LAAO and Afib concomitant procedure with VeriSight Clinical Image
1/2
VeriSight Cost Savings Economic Benefits
Amin Still Video
Footnotes
  1. Diaz JC, Bastidas O, Duque M, et al. Impact of intracardiac echocardiography versus transesophageal echocardiography guidance on left atrial appendage occlusion procedures: A meta‐analysis. J. Cardiovasc. Electrophysiol. 2024; 35(1)44-57.
  2. Amin, AK, Robinson, A, Gundrum E, et al. Intracardiac echocardiography guided left atrial appendage closure contributes to significant cost savings and reduced length of stay. Heart Rhythm. 2019; 16(5) May Supplement: S128.
  3. Dallan LAP et al. Safety, Efficacy, and Cost-Effectiveness of Same-Day Discharge for Left Atrial Appendage Occlusion. J Invasive Cardiol. 2022; 34(2): E124-E131
  4. Jhand A, et al. Intracardiac echocardiography versus transesophageal echocardiography for left atrial appendage closure: an updated meta-analysis and systematic review. Am J Cardiovasc Dis. 2020; 10(5):538-547. PMID: 33489456 PMCID: PMC7811919
  5. Liang G, et al. Imaging with intracardiac echocardiography compared to transesophageal echocardiography during left atrial appendage occlusion. Rev Cardiovasc Med. 2020; 21(1):93-101. DOI: 10.31083/j.rcm.2020.01.569
  6. Akella K, et al. Evaluating the role of transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) in left atrial appendage occlusion: a meta-analysis. 2021. J Interv Card Electrophysiol. 2021;60:41-48. DOI: 10.1007/s10840-019-00677-x
  7. El-Zein RS, Volio A, Khan Z, et al. Healthcare resource utilization for three-dimensional intracardiac echocardiography versus transesophageal echocardiography image guidance for left atrial appendage occlusion. Poster presented at: Heart Rhythm Society Annual Scientific Sessions; April 25, 2025; San Diego, CA.
  8. Sularz, A, Chavez Ponce, A, Al-Abcha, A. et al. Safety and Feasibility of 3D Intracardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With WATCHMAN FLX. JACC Adv. 2025 Feb, 4 (2)
  9. Alkhouli M, et al. Outcomes of Routine Intracardiac Echocardiography to Guide Left Atrial Appendage Occlusion. JACC: Clin Electrophys. 2020; 6(4):393-400. DOI: 10.1016/j.jacep.2019.11.014
  10. Hemam ME, et al. Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: Procedural and cost considerations. Heart Rhythm. 2019; 16:334-342. DOI: 10.1016/j. hrthm.2018.12.013
  11. Pommier T, et al. Safety and efficacy of left atrial appendage occlusion with the ACP or Watchman device guided by intracardiac echocardiography from the left atrium. Clin Cardiol. 2021; 44:1402-1408. DOI: 10.1002/clc.23696
  12. Hussain K, et al. Impact of moderate sedation on electrophysiology lab time for left atrial appendage occlusion using 4D‐intracardiac echocardiography. J Cardiovasc Electrophysiol. 2024: Nov. DOI: 10.1111/ jce.16445
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.
Take control of LAAO with VeriSight Pro. Request an economic assessment today.